Aspect Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.76K Buy
32
+14
+78% +$1.23K ﹤0.01% 489
2026
Q2
$1.41K Sell
18
-44
-71% -$3.55K ﹤0.01% 541
2026
Q1
$5.37K Hold
62
– – ﹤0.01% 350
2025
Q4
$5.96K Buy
62
+16
+35% +$1.55K ﹤0.01% 351
2025
Q3
$4.38K Sell
46
-129
-74% -$11.9K ﹤0.01% 436
2025
Q2
$15.3K Buy
175
+145
+483% +$12.3K 0.01% 242
2025
Q1
$2.7K Hold
30
– – ﹤0.01% 420
2024
Q4
$2.4K Hold
30
– – ﹤0.01% 460
2024
Q3
$2.7K Hold
30
– – ﹤0.01% 418
2024
Q2
$2.36K Hold
30
– – ﹤0.01% 448
2024
Q1
$2.62K Hold
30
– – ﹤0.01% 428
2023
Q4
$2.47K Buy
+30
New +$2.29K ﹤0.01% 416

Other funds holding MDT

Aspect Partners's MDT Position: Q3 2026 in Review

Aspect Partners increased its Medtronic (MDT) stake by 78% in Q3 2026, buying an estimated $1.23K and bringing the position to 32 shares worth $2.76K. The position accounts for ﹤0.01% of the portfolio, ranked #489.

Aspect Partners first reported a position in MDT in Q4 2023 and has held it in 12 quarters since. The position peaked at $15.3K in Q2 2025. 644 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • Aspect Partners held 32 shares of Medtronic worth $2.76K as of Q3 2026.
  • Aspect Partners bought 14 Medtronic shares in Q3 2026, an estimated $1.23K.
  • Medtronic made up ﹤0.01% of Aspect Partners's portfolio in Q3 2026, its #489 holding.
  • Aspect Partners first reported a position in Medtronic in Q4 2023 and has held it in 12 quarters since.
  • Aspect Partners's Medtronic position peaked at $15.3K in Q2 2025.
  • 644 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on Aspect Partners's 13F filing for Q3 2026, filed 20 Oct 2026.